Merck KGaA (OTCMKTS:MKGAF), headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses. Its Healthcare division develops and commercializes prescription pharmaceuticals and biopharmaceutical therapies across areas such as oncology, immunology and fertility, and it provides related clinical development and manufacturing capabilities. The Life Science business supplies research- and manufacturing-critical products and services to academic, biotech and pharmaceutical customers worldwide — including lab reagents, filters, chromatography media and instruments; in the U.S. and Canada this business is widely known under the MilliporeSigma name following strategic acquisitions. The Performance Materials segment produces specialty chemicals and advanced materials for electronics, display and semiconductor applications, offering materials used in consumer electronics, data centers and industrial processes.
Merck KGaA has grown through a combination of internal R&D and strategic acquisitions, notably expanding its life science footprint through the acquisitions of Millipore and Sigma-Aldrich. The company emphasizes investment in research and development, partnerships with academic and industry collaborators, and global manufacturing and distribution networks to support clients across the pharmaceutical, biotechnology and high-tech supply chains. In North America, certain pharmaceutical activities operate under the EMD Serono brand to reflect regional branding conventions.
Leadership is focused on strengthening innovation and sustainable growth; Belén Garijo serves as Chair of the Executive Board and CEO, bringing experience from the company’s healthcare operations. Merck KGaA’s diversified mix of pharmaceuticals, life-science tools and performance materials positions it as a broad-based supplier to both healthcare and high-tech industries with a global footprint and long history of scientific activity.
